Woman and Man | Between 18 years et 85 years
- | Country :
- France
- | organs :
- Carcinomes cutanés
- | Specialty :
- Immunothérapie - Vaccinothérapie
Extract
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630)